American Trust - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
American Trust ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,077
-32.2%
23,333
-22.2%
0.00%0.0%
Q2 2023$13,395
-41.0%
30,000
+8.4%
0.00%
-50.0%
Q1 2023$22,686
-47.4%
27,6660.0%0.00%
-50.0%
Q4 2022$43,159
-10.1%
27,6660.0%0.00%0.0%
Q3 2022$48,0000.0%27,6660.0%0.00%0.0%
Q2 2022$48,000
-40.7%
27,666
+22.1%
0.00%
-20.0%
Q1 2022$81,000
-27.0%
22,666
+2.3%
0.01%
-37.5%
Q4 2021$111,00022,1660.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sante Capital Fund, LP 115,637$1,072,0000.44%
Defender Capital, LLC. 135,466$1,255,0000.42%
Green Alpha Advisors, LLC 62,566$580,0000.40%
Harvest Investment Services, LLC 51,239$474,0000.20%
SEVEN EIGHT CAPITAL, LP 118,270$1,096,0000.15%
Cedar Brook Financial Partners, LLC 54,500$505,0000.15%
WASATCH ADVISORS LP 3,576,706$33,156,0000.14%
Banco BTG Pactual S.A. 20,000$185,0000.12%
Keystone Financial Group 60,712$563,0000.10%
Virtus ETF Advisers LLC 25,105$233,0000.10%
View complete list of INOVIO PHARMACEUTICALS INC shareholders